Cargando…

Prostate cancer – a biomarker perspective

Despite early detection and reduced risk of death, prostate cancer still remains the second leading cause of cancer death in American men. There is currently no cure for advanced prostate cancer. The multistage, stochastic and highly heterogeneous nature of prostate cancer, coupled with genetic and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yanqiu, Hegde, Priti, Zhang, Fengmin, Hampton, Garret, Jia, Shidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361745/ https://www.ncbi.nlm.nih.gov/pubmed/22661971 http://dx.doi.org/10.3389/fendo.2012.00072

Ejemplares similares

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer
por: Lin, Jingwei, et al.
Publicado: (2023)

The genomic landscape of prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2012)

Association between the metabolic score for insulin resistance (METS-IR) and estimated glomerular filtration rate (eGFR) among health check-up population in Japan: A retrospective cross-sectional study
por: Liu, Gailing, et al.
Publicado: (2022)

Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
por: Xie, Ziyan, et al.
Publicado: (2022)

Metabolic syndrome and metastatic prostate cancer correlation study, a real-world study in a prostate cancer clinical research center, Xinjiang, China
por: An, Hengqing, et al.
Publicado: (2022)

Genomic and epigenomic alterations in prostate cancer
por: Aschelter, Anna M., et al.
Publicado: (2012)

Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease
por: Ren, Xuejing, et al.
Publicado: (2023)

CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
por: Chen, Xi, et al.
Publicado: (2022)

Estrogen-Related Receptors in Breast Cancer and Prostate Cancer
por: Misawa, Aya, et al.
Publicado: (2015)

Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer
por: Cao, Lin-Lin, et al.
Publicado: (2022)

Long non-coding RNAs in bone metastasis: progresses and perspectives as potential diagnostic and prognostic biomarkers
por: Maroni, Paola, et al.
Publicado: (2023)

Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer
por: Harris, Anna E., et al.
Publicado: (2022)

Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer
por: Li, Yuezheng, et al.
Publicado: (2023)

Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study
por: Yao, Jiping, et al.
Publicado: (2021)

Endocrine and paracrine characteristics of neuroendocrine prostate cancer
por: Arman, Tarana, et al.
Publicado: (2022)

Use of PARP inhibitors in prostate cancer: from specific to broader application
por: Zhang, Zhenting, et al.
Publicado: (2023)

Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
por: Guo, Yuna, et al.
Publicado: (2022)

Associations Between Vertebral Marrow Proton Density Fat Fraction and Risk of Prostate Cancer
por: Li, Shaojun, et al.
Publicado: (2022)

A Changing Landscape in Castration-Resistant Prostate Cancer Treatment
por: Felici, A., et al.
Publicado: (2012)

Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19
por: Wang, Stephani C., et al.
Publicado: (2022)

Emerging Targeted Therapies for Castration-Resistant Prostate Cancer
por: Adamo, Vincenzo, et al.
Publicado: (2012)

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer
por: Leung, Jacky K., et al.
Publicado: (2017)

Insulin Receptor Isoform Variations in Prostate Cancer Cells
por: Perks, Claire M., et al.
Publicado: (2016)

Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
por: Lo, Chen Hao, et al.
Publicado: (2018)

New Insights and Emerging Therapeutic Approaches in Prostate Cancer
por: Licitra, Fabrizio, et al.
Publicado: (2022)

Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer
por: Jaiswal, Bharti, et al.
Publicado: (2022)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
por: Feng, Yuanfa, et al.
Publicado: (2023)

Proteoglycans—Biomarkers and Targets in Cancer Therapy
por: Nikitovic, Dragana, et al.
Publicado: (2018)

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer
por: Bae, Song Yi, et al.
Publicado: (2023)

Is the Bench Getting Closer to the Bedside in the War on Cancer? A Quick Look at Prostate Cancer
por: Kypta, Robert, et al.
Publicado: (2012)

Luteinizing hormone-releasing hormone agonists versus orchiectomy in the treatment of prostate cancer: A systematic review
por: Zhang, Xianlu, et al.
Publicado: (2023)

Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study
por: Tao, Huan, et al.
Publicado: (2020)

C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis
por: Zhou, Kechong, et al.
Publicado: (2023)

Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease
por: Straign, Desiree M., et al.
Publicado: (2021)

Immunosuppressive environment in response to androgen deprivation treatment in prostate cancer
por: Qin, Caipeng, et al.
Publicado: (2022)

Editorial: March 2022: Ovarian and prostate cancer awareness month
por: Di Donato, Marzia
Publicado: (2023)

Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor
por: Souza, Deborah Simão, et al.
Publicado: (2023)

Regulation of SPDEF expression by DNA methylation in advanced prostate cancer
por: Vatanmakanian, Mousa, et al.
Publicado: (2023)

Isomer-Resolved Imaging of Prostate Cancer Tissues Reveals Specific Lipid Unsaturation Profiles Associated With Lymphocytes and Abnormal Prostate Epithelia
por: Young, Reuben S. E., et al.
Publicado: (2021)

Causal associations of hyperthyroidism with prostate cancer, colon cancer, and leukemia: a Mendelian randomization study
por: Xu, Feipeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pll4e3d5rksqhvksd6vsbuefu9